Joulain F, Borsos K, Cheng WH, Engroba-Teijeiro C, et al. Letter to the editor regarding "Cost-effectiveness of benralizumab versus mepolizumab and dupilumab in patients with severe uncontrolled eosinophilic asthma in Spain". J Asthma 2024 Sep 21:1-3. doi: 10.1080/02770903.2024.2394145.
PMID: 39305273